Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Alzamend Neuro Inc

ALZN
Current price
0.87 USD -0.027 USD (-2.98%)
Last closed 0.85 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 625 954 USD
Yield for 12 month +56.93 %
1Y
3Y
5Y
10Y
15Y
ALZN
21.11.2021 - 28.11.2021

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Address: 3480 Peachtree Road NE, Atlanta, GA, United States, 30326

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 120 157 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -166.06 %
PEG Ratio
Return On Equity TTM -496.81 %
Wall Street Target Price 25 USD
Revenue TTM
Book Value -0.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.28 USD
Diluted Eps TTM -2.28 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALZN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 31.10.2023
Dividend Date

Stock Valuation ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.3589
Price Book MRQ 7.2255

Financials ALZN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALZN

For 52 weeks

0.74 USD 11.91 USD
50 Day MA 0.93 USD
Shares Short Prior Month 72 257
200 Day MA 4.23 USD
Short Ratio 1.16
Shares Short 42 307
Short Percent 1.08 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds


S

SX7EEX

11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics